Kodiak Sciences Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
KOD$108.06+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Operating expenses | ||||
| Research and development | $31,878 | $36,188 | $94,323 | $159,669 |
| General and administrative | 14,754 | 18,312 | 46,347 | 54,278 |
| Total operating expenses | 46,632 | 54,500 | 140,670 | 213,947 |
| Loss from operations | (46,632) | (54,500) | (140,670) | (213,947) |
| Interest income | 2,711 | 4,536 | 9,018 | 12,836 |
| Interest expense | — | (5) | — | (13) |
| Other income (expense), net | (25) | (38) | (450) | 149 |
| Net loss | $(43,946) | $(50,007) | $(132,102) | $(200,975) |
| Net loss per common share, basic and diluted | $(0.84) | $(0.95) | $(2.51) | $(3.84) |
| Weighted-average shares of common stock outstanding used in computing net loss per common share, basic and diluted | 52,616,183 | 52,455,620 | 52,560,489 | 52,391,083 |
| Other comprehensive income (loss) | ||||
| Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | — | — | — | 1,307 |
| Total other comprehensive income (loss) | — | — | — | 1,307 |
| Comprehensive loss | $(43,946) | $(50,007) | $(132,102) | $(199,668) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.